Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00267787
Status:
TERMINATED
Last Update Posted:
2018-12-10
First Post:
2005-12-19
Brief Title:
Molecular Genetic and Pathological Studies of Anal Tumors
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Molecular Genetic and Pathological Studies of Anal Tumors
Status:
TERMINATED
Status Verified Date:
2018-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study the Genetics of Anal Cancer
Detailed Description:
To determine the status of previously identified anal cancer molecular markers and any correlations with outcome as well as to discover new molecular biomarkers through correlating molecular data with clinical outcome Study of tissue samples and cells from biopsies of your lesion and blood sample We hope to learn the role genes and proteins may play in the development of anal cancer Experiments will be performed using this tissue and blood include analysis of DNA analysis of RNA expression levels analysis of protein levels of important gene products and development of tissue culture cell lines
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 14037 | OTHER | Stanford IRB | None |
| 95340 | OTHER | None | None |
| ANAL0001 | OTHER | None | None |